Biotech
LAWRENCE, MA: Closes $1.6 Million Convertible Debt Offering ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/03/16 -- Hemostemix Inc. (the "Corporation") (TSX VENTURE: HEM)(OTCQB: HMTXF), a clinical-stage autologous cell-therapy company, announces that two ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/03/16 -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE: GLH)(CSE: GLH.CN), a leading cannabis oil solutions company built around ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 10/03/16 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") announced today that it will be conduct ...
LONDON, ONTARIO: Pharma Veteran Scott Langille Brings Over 25 Years of Experience in Both Canada and the United States to Sernova ...
GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 09/30/16 -- ANGLE plc (AIM: AGL) (OTCQX: ANPCY)("ANGLE" or "the Company")ANGLE plc (AIM: AGL) (OTCQX: ANPCY), the specialist medtech ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 09/29/16 -- (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products announced the successful applicati ...
LAS VEGAS, NEVADA: LAS VEGAS, NEVADA -- (Marketwired) -- 09/29/16 -- Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company") a development stage company focused on the commercialization of th ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 09/28/16 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it will move forward with the development of the F4 single vial formulation ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 09/28/16 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 09/27/16 -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/27/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCD)(TSX VENTURE: RP)(FRANKFURT: P6P2) ("RepliCel" or the "Company"), a clinical ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/27/16 -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing peptide-based cancer therapeutic ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 09/27/16 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/26/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCD)(TSX VENTURE: RP)(FRANKFURT: P6P2) ("RepliCel" or the "Company"), a clinical ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 09/26/16 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") today announced the voting results from its annual general and special meeting ( ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/26/16 -- Pacific Therapeutics Ltd. (CSE: PT)(OTC PINK: PCFTF)(Frankfurt: 1P3) (the "Company") announces that it has received a corporate ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 09/26/16 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") is scheduled to present at the on Tuesday, September 27, 2016 at 10:00 AM ET. Th ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 09/26/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)First-Ever Vehicle-Controlled Phase III Clinical Trial in Noninfectious Anterior UveitisFirst-Ever Phase III Cli ...
HALIFAX, NOVA SCOTIA: Presentations at RSV16, World Vaccine Congress Europe and IDWeek Conferences Highlight Company's Progress in Using DepoVax(TM)-based Agents to Address Respiratory Syncytial Virus (RSV) and Life-T ...
